SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-06-002531
Filing Date
2006-02-15
Accepted
2006-02-15 13:52:11
Documents
2
Period of Report
2005-07-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4097
2 POWER OF ATTORNEY poa1.htm EX-24.1 8600
  Complete submission text file 0001140361-06-002531.txt   14554
Mailing Address 34801 CAMPUS DR FREMONT CA 94555
Business Address 34801 CAMPUS DR FREMONT CA 94555 5105741400
PDL BIOPHARMA, INC. (Issuer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 34801 CAMPUS DRIVE FREMONT CA 94555
Business Address 510-574-1400
Iwanicki David (Reporting) CIK: 0001322481 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19756 | Film No.: 06621205